US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 1.290
  • +0.080+6.61%
Close Nov 21 16:00 ET
  • 1.340
  • +0.050+3.88%
Post 20:01 ET
68.04MMarket Cap-434P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-38.87%32.57M
12.91%41.53M
17.26%37.76M
33.62%170.28M
49.05%48.02M
45.24%53.28M
8.84%36.78M
30.13%32.2M
52.52%127.44M
13.16%32.22M
Selling and administrative expenses
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
-1.90%28.48M
-11.15%6.24M
2.88%7.51M
3.61%7.3M
-3.05%7.44M
24.17%29.04M
-7.34%7.02M
-General and administrative expense
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
-1.90%28.48M
-11.15%6.24M
2.88%7.51M
3.61%7.3M
-3.05%7.44M
24.17%29.04M
-7.34%7.02M
Research and development costs
-42.16%26.47M
17.54%34.65M
28.08%31.72M
44.10%141.8M
65.83%41.78M
55.76%45.77M
10.22%29.48M
45.04%24.76M
63.54%98.4M
20.59%25.2M
Operating profit
38.87%-32.57M
-12.91%-41.53M
-17.26%-37.76M
-33.62%-170.28M
-49.05%-48.02M
-45.24%-53.28M
-8.84%-36.78M
-30.13%-32.2M
-52.52%-127.44M
-13.16%-32.22M
Net non-operating interest income expense
-18.77%1.86M
-6.97%2.13M
14.09%2.2M
124.85%9.08M
63.71%2.58M
67.11%2.29M
162.47%2.29M
766.67%1.92M
5,079.49%4.04M
19,600.00%1.58M
Non-operating interest income
-13.97%2.3M
-3.86%2.56M
13.46%2.62M
148.92%10.65M
65.74%3M
95.40%2.68M
204.34%2.67M
927.11%2.31M
4,601.10%4.28M
8,504.76%1.81M
Non-operating interest expense
14.07%446K
15.32%429K
10.34%427K
557.56%1.57M
79.65%415K
19,450.00%391K
18,500.00%372K
12,800.00%387K
1,730.77%238K
--231K
Other net income (expense)
400.00%3K
-102.47%-8K
-114.74%-14K
1,868.18%389K
-1,350.00%-29K
85.71%-1K
6,580.00%324K
1,287.50%95K
-214.29%-22K
-140.00%-2K
Other non- operating income (expenses)
400.00%3K
-102.47%-8K
-114.74%-14K
1,868.18%389K
-1,350.00%-29K
85.71%-1K
6,580.00%324K
1,287.50%95K
-214.29%-22K
-140.00%-2K
Income before tax
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.29%-160.81M
-48.38%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
-47.83%-123.42M
-7.68%-30.65M
Income tax
0
404.76%64K
Net income
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
-47.95%-123.48M
-7.99%-30.71M
Net income continuous Operations
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
-47.95%-123.48M
-7.99%-30.71M
Minority interest income
Net income attributable to the parent company
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
-47.95%-123.48M
-7.99%-30.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
-30.23%-160.81M
-48.07%-45.47M
-44.37%-50.99M
-3.76%-34.16M
-23.03%-30.18M
-47.95%-123.48M
-7.99%-30.71M
Basic earnings per share
53.23%-0.58
9.52%-0.76
4.05%-0.71
-23.43%-3.74
-22.67%-0.92
-42.53%-1.24
-3.70%-0.84
-23.33%-0.74
-46.38%-3.03
-7.14%-0.75
Diluted earnings per share
53.23%-0.58
9.52%-0.76
4.05%-0.71
-23.43%-3.74
-22.67%-0.92
-42.53%-1.24
-3.70%-0.84
-23.33%-0.74
-46.38%-3.03
-7.14%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -38.87%32.57M12.91%41.53M17.26%37.76M33.62%170.28M49.05%48.02M45.24%53.28M8.84%36.78M30.13%32.2M52.52%127.44M13.16%32.22M
Selling and administrative expenses -18.82%6.1M-5.80%6.87M-18.75%6.05M-1.90%28.48M-11.15%6.24M2.88%7.51M3.61%7.3M-3.05%7.44M24.17%29.04M-7.34%7.02M
-General and administrative expense -18.82%6.1M-5.80%6.87M-18.75%6.05M-1.90%28.48M-11.15%6.24M2.88%7.51M3.61%7.3M-3.05%7.44M24.17%29.04M-7.34%7.02M
Research and development costs -42.16%26.47M17.54%34.65M28.08%31.72M44.10%141.8M65.83%41.78M55.76%45.77M10.22%29.48M45.04%24.76M63.54%98.4M20.59%25.2M
Operating profit 38.87%-32.57M-12.91%-41.53M-17.26%-37.76M-33.62%-170.28M-49.05%-48.02M-45.24%-53.28M-8.84%-36.78M-30.13%-32.2M-52.52%-127.44M-13.16%-32.22M
Net non-operating interest income expense -18.77%1.86M-6.97%2.13M14.09%2.2M124.85%9.08M63.71%2.58M67.11%2.29M162.47%2.29M766.67%1.92M5,079.49%4.04M19,600.00%1.58M
Non-operating interest income -13.97%2.3M-3.86%2.56M13.46%2.62M148.92%10.65M65.74%3M95.40%2.68M204.34%2.67M927.11%2.31M4,601.10%4.28M8,504.76%1.81M
Non-operating interest expense 14.07%446K15.32%429K10.34%427K557.56%1.57M79.65%415K19,450.00%391K18,500.00%372K12,800.00%387K1,730.77%238K--231K
Other net income (expense) 400.00%3K-102.47%-8K-114.74%-14K1,868.18%389K-1,350.00%-29K85.71%-1K6,580.00%324K1,287.50%95K-214.29%-22K-140.00%-2K
Other non- operating income (expenses) 400.00%3K-102.47%-8K-114.74%-14K1,868.18%389K-1,350.00%-29K85.71%-1K6,580.00%324K1,287.50%95K-214.29%-22K-140.00%-2K
Income before tax 39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.29%-160.81M-48.38%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M-47.83%-123.42M-7.68%-30.65M
Income tax 0404.76%64K
Net income 39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M-47.95%-123.48M-7.99%-30.71M
Net income continuous Operations 39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M-47.95%-123.48M-7.99%-30.71M
Minority interest income
Net income attributable to the parent company 39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M-47.95%-123.48M-7.99%-30.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.78%-30.71M-15.34%-39.4M-17.88%-35.58M-30.23%-160.81M-48.07%-45.47M-44.37%-50.99M-3.76%-34.16M-23.03%-30.18M-47.95%-123.48M-7.99%-30.71M
Basic earnings per share 53.23%-0.589.52%-0.764.05%-0.71-23.43%-3.74-22.67%-0.92-42.53%-1.24-3.70%-0.84-23.33%-0.74-46.38%-3.03-7.14%-0.75
Diluted earnings per share 53.23%-0.589.52%-0.764.05%-0.71-23.43%-3.74-22.67%-0.92-42.53%-1.24-3.70%-0.84-23.33%-0.74-46.38%-3.03-7.14%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data